Literature DB >> 18953086

Modulation by testosterone of an endogenous hERG potassium channel current.

J M Ridley1, Y M Shuba, A F James, J C Hancox.   

Abstract

hERG (human ether-a-go-go-related gene) potassium (K+) channels are expressed in a range of tissue types including neuroblastoma cells and the heart, in which hERG K+ current is important for action potential repolarization. Whilst gender differences in cardiac repolarization and the QT interval of the cardiac electrocardiogram are well-established, comparatively little is known about regulation of hERG channels by sex hormones. In this study, whole-cell patch-clamp recordings were made at 37 degrees C from SH-SY5Y human neuroblastoma cells to investigate modulation of endogenous hERG K+ channel current (I(hERG)) by testosterone. Acutely applied testosterone at a physiologically relevant concentration (10 nM) produced a modest (approximately 13-15 %) increase in I(hERG) amplitude, whilst a high concentration (1 microM) slightly decreased I(hERG). The stimulatory effect of testosterone was inhibited by the androgen receptor antagonist flutamide (10 microM) and the PI-3 kinase inhibitor wortmannin (1 microM). Chronic (24 h) application of testosterone also augmented IhERG via flutamide-sensitive receptor activation, without modulation of the current's voltage-dependence. These results demonstrate for the first time that testosterone can stimulate (hERG) K+ channels via activation of classical androgen receptors and implicate PI-3 kinase in the acute response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18953086

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  12 in total

1.  Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2.

Authors:  Jonathan Buber; Jehu Mathew; Arthur J Moss; W Jackson Hall; Alon Barsheshet; Scott McNitt; Jennifer L Robinson; Wojciech Zareba; Michael J Ackerman; Elizabeth S Kaufman; David Luria; Michael Eldar; Jeffrey A Towbin; Michael Vincent; Ilan Goldenberg
Journal:  Circulation       Date:  2011-05-31       Impact factor: 29.690

2.  Short QT interval linked to androgen misuse: wider significance and possible basis.

Authors:  Jules C Hancox; Stéphanie C Choisy; Andrew F James
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

3.  Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome.

Authors:  Dimitry Migdalovich; Arthur J Moss; Coeli M Lopes; Jason Costa; Gregory Ouellet; Alon Barsheshet; Scott McNitt; Slava Polonsky; Jennifer L Robinson; Wojciech Zareba; Michael J Ackerman; Jesaia Benhorin; Elizabeth S Kaufman; Pyotr G Platonov; Wataru Shimizu; Jeffrey A Towbin; G Michael Vincent; Arthur A M Wilde; Ilan Goldenberg
Journal:  Heart Rhythm       Date:  2011-03-25       Impact factor: 6.343

4.  Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome.

Authors:  Jason Costa; Coeli M Lopes; Alon Barsheshet; Arthur J Moss; Dmitriy Migdalovich; Gregory Ouellet; Scott McNitt; Slava Polonsky; Jennifer L Robinson; Wojciech Zareba; Michael J Ackerman; Jesaia Benhorin; Elizabeth S Kaufman; Pyotr G Platonov; Wataru Shimizu; Jeffrey A Towbin; G Michael Vincent; Arthur A M Wilde; Ilan Goldenberg
Journal:  Heart Rhythm       Date:  2012-01-28       Impact factor: 6.343

Review 5.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 6.  Testosterone replacement therapy and cardiovascular risk.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

7.  Clinical Implications and Gender Differences of KCNQ1 p.Gly168Arg Pathogenic Variant in Long QT Syndrome.

Authors:  Rebeca Lorca; Alejandro Junco-Vicente; Maria Martin-Fernandez; Isaac Pascual; Andrea Aparicio; Noemi Barja; Elias Cuesta-LLavona; Luis Roces; Pablo Avanzas; Cesar Moris; Eliecer Coto; José Julían Rodríguez Reguero; Juan Gómez
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

8.  The association of serum testosterone levels and ventricular repolarization.

Authors:  Charlotte van Noord; Marcus Dörr; Miriam C J M Sturkenboom; Sabine M J M Straus; Thorsten Reffelmann; Stephan B Felix; Albert Hofman; Jan A Kors; Robin Haring; Frank H de Jong; Matthias Nauck; André G Uitterlinden; Henri Wallaschofski; Jacqueline C M Witteman; Henry Völzke; Bruno H Ch Stricker
Journal:  Eur J Epidemiol       Date:  2009-12-03       Impact factor: 8.082

9.  The KCNH2 genetic polymorphism (1956, C>T) is a novel biomarker that is associated with CCB and α,β-ADR blocker response in EH patients in China.

Authors:  Fazhong He; Jianquan Luo; Zhiying Luo; Lan Fan; Yijing He; Dingliang Zhu; Jinping Gao; Sheng Deng; Yan Wang; Yuesheng Qian; Honghao Zhou; Xiaoping Chen; Wei Zhang
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

10.  Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer.

Authors:  Thiago Gagliano-Jucá; Thomas G Travison; Philip W Kantoff; Paul L Nguyen; Mary-Ellen Taplin; Adam S Kibel; Grace Huang; Richelle Bearup; Haley Schram; Robert Manley; Yusnie M Beleva; Robert R Edwards; Shehzad Basaria
Journal:  J Endocr Soc       Date:  2018-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.